SZSE:002390 (China)
Â
Class A
Â¥
3.40
(+2.72%)
Jul 5
New Key Statistics Module, Z-Score and F-Score
SZSE:002390 Key Ratios
Market Cap ¥ M | 6,609.10 |
Enterprise Value ¥ M | 6,734.32 |
P/E(ttm) | 22.67 |
PE Ratio without NRI | 18.89 |
Forward PE Ratio | -- |
Price/Book | 0.96 |
Price/Sales | 1.03 |
Price/Free Cash Flow | 10.49 |
Price/Owner Earnings | 51.52 |
Payout Ratio % | 0.33 |
Revenue (TTM) ¥ M | 6,438.00 |
EPS (TTM) ¥ | 0.15 |
Beneish M-Score | -2.63 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 20.90 |
EV-to-EBIT | 15.45 |
EV-to-EBITDA | 15.45 |
PEG | -- |
Shares Outstanding M | 1,943.85 |
Net Margin (%) | 4.55 |
Operating Margin % | 7.31 |
Pre-tax Margin (%) | 6.27 |
Quick Ratio | 2.27 |
Current Ratio | 2.77 |
ROA % (ttm) | 3.08 |
ROE % (ttm) | 4.27 |
ROIC % (ttm) | 5.69 |
Dividend Yield % | 1.76 |
Altman Z-Score | 3.43 |
SZSE:002390 Number of Guru Trades
SZSE:002390 Volume of Guru Trades
Gurus Latest Trades with SZSE:002390
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002390 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guizhou Xinbang Pharmaceutical Co Ltd Insider Transactions
No Available Data